Skin mast cell

Skin mast cells are specialized, long-lived secretory immune cells located within the dermis that serve as key effectors in the skin's immune surveillance and inflammatory response (StatPearls, 2023). Unlike mast cells in the lung or gut mucosa, skin mast cells are predominantly of the connective tissue type (MC_TC), characterized by the presence of both tryptase and chymase in their granules (Journal of Investigative Dermatology, 2018). They are uniquely defined by the high expression of the Mas-related G protein-coupled receptor member X2 (MRGPRX2), which allows for rapid, IgE-independent degranulation in response to various cationic substances, including certain drugs and neuropeptides (Nature Reviews Immunology, 2015). These cells play a pivotal role in the pathogenesis of chronic spontaneous urticaria, atopic dermatitis, and mastocytosis by releasing potent mediators like histamine, leukotrienes, and cytokines (JACI, 2014). Therapeutic targeting of skin mast cells involves stabilizing the cell membrane, blocking high-affinity IgE receptors (FcεRI), or inhibiting the KIT (CD117) receptor tyrosine kinase, which is critical for mast cell differentiation and survival (NEJM, 2021). While "Skin mast cells" refers to a cell type rather than a single molecular target, the specific receptors and enzymes they express are the primary focus of drug development in dermatology.

Other names

Dermal mast cellConnective tissue mast cellMC_TC

Inhibition of KIT signaling to reduce cell survival, antagonism of MRGPRX2 to prevent non-IgE mediated degranulation, and sequestration of IgE to prevent FcεRI-mediated activation.